| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
248,929 |
165,334 |
$27.99M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
89,759 |
75,584 |
$11.97M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17,206 |
16,432 |
$3.85M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16,225 |
14,740 |
$3.06M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,456 |
12,590 |
$2.87M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
11,468 |
10,937 |
$2.35M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
58,139 |
40,974 |
$2.16M |
| S0281 |
Medical home program, comprehensive care coordination and planning, maintenance of plan |
5,454 |
5,102 |
$663K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,439 |
3,279 |
$595K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,665 |
6,500 |
$445K |
| H0036 |
Community psychiatric supportive treatment, face-to-face, per 15 minutes |
5,813 |
2,461 |
$229K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,380 |
1,328 |
$87K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
4,326 |
2,004 |
$74K |
| 90834 |
Psychotherapy, 45 minutes with patient |
23,619 |
11,371 |
$65K |
| 90832 |
Psychotherapy, 30 minutes with patient |
25,671 |
12,658 |
$46K |
| 90837 |
Psychotherapy, 53 minutes with patient |
6,880 |
3,789 |
$35K |
| 99381 |
|
211 |
208 |
$34K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
590 |
564 |
$22K |
| 0002A |
|
619 |
566 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
466 |
391 |
$13K |
| 0001A |
|
588 |
525 |
$13K |
| 0011A |
|
557 |
486 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13,851 |
13,565 |
$11K |
| 0072A |
|
496 |
443 |
$11K |
| 0012A |
|
470 |
432 |
$11K |
| D0120 |
Periodic oral evaluation - established patient |
319 |
319 |
$11K |
| 87428 |
|
2,641 |
2,512 |
$10K |
| 0071A |
|
512 |
477 |
$10K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
5,555 |
2,150 |
$9K |
| 90791 |
Psychiatric diagnostic evaluation |
1,582 |
1,506 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
563 |
486 |
$7K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
45 |
42 |
$6K |
| D0274 |
Bitewings - four radiographic images |
145 |
145 |
$6K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
3,267 |
2,436 |
$6K |
| 92551 |
|
14,538 |
14,074 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,843 |
4,770 |
$5K |
| 0081A |
|
406 |
346 |
$5K |
| 90686 |
|
21,682 |
20,618 |
$5K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
2,559 |
1,724 |
$4K |
| D1110 |
Prophylaxis - adult |
60 |
60 |
$4K |
| G0008 |
Administration of influenza virus vaccine |
441 |
269 |
$3K |
| D1208 |
Topical application of fluoride, excluding varnish |
104 |
104 |
$3K |
| 97803 |
|
1,127 |
1,054 |
$3K |
| 96127 |
|
26,298 |
24,965 |
$2K |
| 0082A |
|
96 |
86 |
$2K |
| 90677 |
|
1,508 |
1,453 |
$2K |
| 0124A |
|
290 |
271 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,043 |
7,583 |
$2K |
| 90480 |
|
591 |
578 |
$2K |
| D1120 |
Prophylaxis - child |
40 |
40 |
$2K |
| D1206 |
Topical application of fluoride varnish |
63 |
63 |
$2K |
| 0074A |
|
98 |
72 |
$2K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
16 |
13 |
$2K |
| 0031A |
|
34 |
32 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
312 |
275 |
$1K |
| 0054A |
|
144 |
131 |
$1K |
| 90715 |
|
631 |
595 |
$1K |
| 0004A |
|
99 |
88 |
$1K |
| 90651 |
|
750 |
732 |
$921.52 |
| 0083A |
|
22 |
17 |
$680.00 |
| 0154A |
|
62 |
51 |
$640.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
46 |
12 |
$567.43 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
30,878 |
29,438 |
$539.42 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
80 |
78 |
$497.08 |
| 96161 |
|
1,674 |
1,617 |
$490.19 |
| D0220 |
Intraoral - periapical first radiographic image |
27 |
27 |
$450.42 |
| 0174A |
|
26 |
22 |
$240.00 |
| 99173 |
|
14,219 |
13,771 |
$239.46 |
| 90710 |
|
633 |
597 |
$209.00 |
| 90461 |
|
16,014 |
15,273 |
$167.49 |
| 99188 |
|
8,208 |
7,849 |
$155.14 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$135.69 |
| 90633 |
|
4,003 |
3,831 |
$123.55 |
| 90670 |
|
6,521 |
6,094 |
$116.00 |
| 90674 |
|
148 |
132 |
$114.09 |
| G0009 |
Administration of pneumococcal vaccine |
18 |
12 |
$114.09 |
| D0140 |
Limited oral evaluation - problem focused |
2,366 |
2,227 |
$88.81 |
| 90656 |
|
1,262 |
1,251 |
$83.44 |
| 90680 |
|
6,105 |
5,868 |
$66.40 |
| 90697 |
|
3,596 |
3,439 |
$44.60 |
| 0052A |
|
12 |
12 |
$40.00 |
| 0171A |
|
12 |
12 |
$40.00 |
| 90661 |
|
100 |
100 |
$33.18 |
| 99177 |
|
5,849 |
5,606 |
$20.96 |
| 90671 |
|
1,975 |
1,919 |
$11.00 |
| 90707 |
|
679 |
659 |
$11.00 |
| 91317 |
|
103 |
92 |
$0.06 |
| 91315 |
|
42 |
36 |
$0.02 |
| 80305 |
|
3,726 |
3,076 |
$0.00 |
| D2999 |
|
321 |
288 |
$0.00 |
| 91300 |
|
1,257 |
1,090 |
$0.00 |
| 91308 |
|
615 |
523 |
$0.00 |
| 81025 |
|
991 |
917 |
$0.00 |
| G0470 |
Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit |
4,001 |
888 |
$0.00 |
| D0145 |
Oral evaluation for a patient under three years of age |
1,512 |
1,454 |
$0.00 |
| 99442 |
|
162 |
120 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
464 |
458 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
56 |
56 |
$0.00 |
| 90734 |
|
235 |
230 |
$0.00 |
| 90700 |
|
313 |
304 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
477 |
237 |
$0.00 |
| 91312 |
|
206 |
189 |
$0.00 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
122 |
120 |
$0.00 |
| 90756 |
|
33 |
31 |
$0.00 |
| 90380 |
|
37 |
37 |
$0.00 |
| 90849 |
|
24 |
13 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
12 |
12 |
$0.00 |
| 90662 |
|
84 |
57 |
$0.00 |
| 91320 |
|
54 |
52 |
$0.00 |
| 11981 |
|
12 |
12 |
$0.00 |
| D0191 |
|
32 |
32 |
$0.00 |
| 90672 |
|
12 |
12 |
$0.00 |
| 90685 |
|
24 |
24 |
$0.00 |
| 90744 |
|
653 |
637 |
$0.00 |
| 90698 |
|
1,853 |
1,820 |
$0.00 |
| 90716 |
|
679 |
652 |
$0.00 |
| 99174 |
|
835 |
780 |
$0.00 |
| 90647 |
|
1,961 |
1,874 |
$0.00 |
| 90688 |
|
104 |
104 |
$0.00 |
| 91307 |
|
1,074 |
945 |
$0.00 |
| 97802 |
|
205 |
199 |
$0.00 |
| 90723 |
|
1,972 |
1,882 |
$0.00 |
| 91318 |
|
117 |
113 |
$0.00 |
| D0999 |
Unspecified diagnostic procedure, by report |
674 |
644 |
$0.00 |
| 90474 |
|
181 |
178 |
$0.00 |
| 91305 |
|
259 |
241 |
$0.00 |
| 91301 |
|
1,030 |
920 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
222 |
215 |
$0.00 |
| T2022 |
Case management, per month |
63 |
24 |
$0.00 |
| 36416 |
|
95 |
86 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28 |
27 |
$0.00 |
| 91303 |
|
34 |
32 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
102 |
93 |
$0.00 |
| 90696 |
|
365 |
348 |
$0.00 |
| 90619 |
|
125 |
121 |
$0.00 |
| 90620 |
|
152 |
151 |
$0.00 |
| 99385 |
|
18 |
18 |
$0.00 |
| 91319 |
|
114 |
112 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
33 |
33 |
$0.00 |
| 90381 |
|
37 |
37 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
84 |
80 |
$0.00 |
| 76801 |
|
13 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
80 |
78 |
$0.00 |
| 81000 |
|
144 |
126 |
$0.00 |
| 90732 |
|
30 |
24 |
$0.00 |
| 99441 |
|
18 |
14 |
$0.00 |